-
Product Insights
Palu refinery, Indonesia
Palu refinery is proposed to be built in Central Sulawesi, Indonesia. It is expected to start operations in 2027. The refinery will be operated by PT Palembang GMA Refinery Consortium. Empower your strategies with our Palu refinery, Indonesia report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – GMA-131
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry GMA-131 Drug Details GMA-131 is under development for the treatment of diabetic nephropathy. The...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – GMA-105
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry GMA-105 Drug Details GMA-105 is under development for the treatment of obesity. The drug...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – GMA-102
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry GMA-102 Drug Details GMA-102 is under development for the treatment of type 2 diabetes....
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – GMA-301
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry GMA-301 Drug Details GMA-301 is under development for the treatment of pulmonary arterial hypertension...
-
Product Insights
Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) pipeline Target constitutes close to 33 molecules. Out of which approximately 30 molecules are developed by companies and remaining by the universities/institutes. The latest report Gastric Inhibitory Polypeptide Receptor – Drugs In Development, 2022, outlays comprehensive information on the Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and...
-
Analyst Opinions
Italy Beer and Cider Market Insights 2017
GlobalData’s Italy Beer and Cider Market Insights 2017 report provides a complete overview of the Italy beer and cider industry structure offering a comprehensive insight into historical background trends, 2016 performance and 2017 outlook. Covering total market (on and off-premise) the report details - - 2011-2016 actual detailed beer consumption volume data by segment, brand, brewer, packaging and distribution (on-/off-premise), with 2017 forecasts. - Value by distribution channel 2011-2016, with 2017 forecasts. - Overview of the competitive landscape in the...